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SUMMARY
Inhibition of glycogen synthase kinase-3 (Gsk3)
supports mouse embryonic stem cells (ESCs) by
modulating Tcf3, but the critical targets downstream
of Tcf3 are unclear. We analyzed the intersection
between genome localization and transcriptome
data sets to identify genes repressed by Tcf3. Among
these, manipulations of Esrrb gave distinctive
phenotypes in functional assays. Knockdown and
knockout eliminated response to Gsk3 inhibition,
causing extinction of pluripotency markers and loss
of colony forming capability. Conversely, forced
expression phenocopied Gsk3 inhibition or Tcf3
deletion by suppressing differentiation and sus-
taining self-renewal. Thus the nuclear receptor Esrrb
is necessary and sufficient to mediate self-renewal
downstream of Gsk3 inhibition. Leukaemia inhibitory
factor (LIF) regulates ESCs through Stat3, indepen-
dently of Gsk3 inhibition. Consistent with parallel
operation, ESCs in LIF accommodated Esrrb dele-
tion and remained pluripotent. These findings high-
light a key role for Esrrb in regulating the naive plurip-
otent state and illustrate compensation among the
core pluripotency factors.
INTRODUCTION
Since the original derivation of mouse embryonic stem cells
(ESCs) in 1981 (Evans and Kaufman, 1981; Martin, 1981), culture
conditions for sustaining pluripotency ex vivo have been
progressively refined. Following the demonstration that the cyto-
kine leukemia inhibitory factor (LIF) could replace feeder cells
(Smith et al., 1988; Williams et al., 1988) and that ESC differenti-
ation is suppressed by inhibition of mitogen activated protein
kinase (Erk) signaling (Burdon et al., 1999; Kunath et al., 2007),
further addition of an inhibitor of glycogen synthase kinase-3
(Gsk3) has enabled robust ESC propagation in well-defined
conditions (Ying et al., 2008). When cultured using the two inhib-
itors (2i), ESCs display rather uniform marker expression (Wray
et al., 2010) and exhibit distinctive gene expression and epige-
netic features (Marks et al., 2012). A practical consequence is
that it has become facile to establish ESCs from different strains
ofmice and also rats (Blair et al., 2011). It is noteworthy that, while
the triple combination of 2i/LIF appears optimal, mouse ESCs
can be propagated by providing any two of these three compo-
nents (Wray et al., 2011;Wray et al., 2010), implying complemen-
tary inputs to a flexible gene regulatory circuit. However, under-
standing how intracellular signaling pathways engage with the
core transcription factor circuitry tomaintain or extinguish plurip-
otency remains fragmentary (Chen et al., 2008; Jaenisch and
Young, 2008; Nichols and Smith, 2012; Niwa et al., 2009).
Gsk3 is a negative regulator of many different proteins (Doble
and Woodgett, 2003), including transcription factors such as
cMyc (Singh and Dalton, 2009). Nonetheless, the effect of Gsk3
inhibition ESC self-renewal is mediated primarily via b-catenin
because ESCs lacking b-catenin do not respond productively
to Gsk3 inhibitors (Lyashenko et al., 2011; Wray et al., 2011).
Consistent with action through intracellular b-catenin, mutation
of Apc or expression of stabilized b-catenin variants can reduce
ESC differentiation (Kielman et al., 2002; Sato et al., 2004).
Furthermore, Wnt3a can partially substitute for Gsk3 inhibition
and support ESC propagation in conjunction with LIF (ten Berge
et al., 2011; Hao et al., 2006; Ogawa et al., 2006; Yi et al., 2011).
It has been suggested that b-catenin might interact directly
with Oct4 to promote pluripotent gene expression (Kelly et al.,
2011). On the other hand, genetic evidence is incontrovertible
that a definitive b-catenin partner, Tcf3 (also known as Tcf7l1),
is a major negative regulator of ESC self-renewal (Guo et al.,
2011; Pereira et al., 2006). Indeed, ablation of Tcf3 phenocopies
deletion or inhibition of Gsk3 (Wray et al., 2011). Genome loca-
tion analyses indicate that Tcf3 binds in proximity to many core
pluripotency genes (Cole et al., 2008; Marson et al., 2008; Tam
et al., 2008). Although it has been proposed that b-catenin is
recruited to stimulate transcription at these sites (Cole et al.,
2008), this model seems inconsistent with the Tcf3 loss of func-
tion phenotype. Furthermore, available evidence indicates that
Tcf3 functions in a repressor complex (Pereira et al., 2006; Sokol,
2011; Yi et al., 2011), activity of which can be abrogated by
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b-catenin without requirement for its transactivation domain
(Wray et al., 2011).
Tcf3 has previously been proposed to act via repression of
Nanog (Pereira et al., 2006). However, Nanog null ESCs retain
responsiveness to Gsk3 inhibition (Silva et al., 2009), and knock-
down of Nanog in Tcf3 null ESCs does not prevent upregulated
expression of other pluripotency genes (Yi et al., 2011). It is
therefore unclear whether Tcf3 functions as a general repressor
of pluripotency genes or acts via a selective target or subset of
targets. To resolve this issue, we integrated available high reso-
lution genome location data with transcriptome profiles from
Tcf3 perturbation studies. This enabled identification of a small
number of transcription factor candidates that were subjected
to loss and gain of function analyses.
RESULTS
Genome-Scale Identification of Candidate Genes
Directly Regulated by Tcf3
Genome-wide mapping of transcription factor binding events is
achievable by chromatin immunoprecipitation and deep
sequencing (ChIP-seq). Integrated analysis of multiple transcrip-
tion factorChIP-seqstudies (Hannahetal., 2011), has thepotential
to provide new mechanistic insights (Ouyang et al., 2009; Wilson
et al., 2010). Given the dominant role of transcriptional regulation
in ESC function (Jaenisch and Young, 2008; Nichols and Smith,
2012; Niwa, 2007; Smith, 2009; Young, 2011) we generated
a compendium of transcription factor ChIP-seq analyses (see
Figures S1A and S1B and Table S1 available online and http://
bioinformatics.cscr.cam.ac.uk/ES_Cell_ChIP-seq_compendium.
html). We used the ChIP-seq compendium to explore candidate
target genes for the Tcf3 transcriptional repressor. We focused
on those Tcf3 ChIP-seq targets also bound by other pluripotency
factors. As previously indicated from promoter-based ChIP-on-
chip analysis (Cole et al., 2008), extensive colocalization of Tcf3
with core pluripotency transcription factors Oct4 and Nanog was
evident in the genome-wide ChIP-seq data sets (Figure 1B).
We then analyzed published gene expression profiles for
ESCs in which Tcf3 has been inactivated, either by gene target-
ing (Yi et al., 2011) or by RNAi (Cole et al., 2008). Tcf3 null and
Tcf3 knockdown ESCs show similarly enhanced self-renewal
so we reasoned that genes differentially expressed in both
studies are likely to underlie this phenotype. Tcf3 appears to
function in ESCs primarily, if not exclusively, as a transcriptional
repressor (Pereira et al., 2006; Wray et al., 2011; Yi et al., 2011).
We therefore focused on genes with increased expression after
Tcf3 inactivation and found 379 genes upregulated in Tcf3 null
cells and 1,972 in Tcf3 knockdown cells (Figure 1C). Of these,
120 genes were common to both groups and therefore were
considered the most likely specific responders.
We intersected the list of Tcf3 target genes from the ChIP-seq
compendiumwith the 120 upregulated genes and found a statis-
tically significant enrichment (p value = 0.0034), with 50 genes
identified as candidates for direct regulation, being both bound
by Tcf3 and derepressed after Tcf3 ablation. The same analysis
for genes downregulated following Tcf3 inactivation did not
show significant enrichment for Tcf3 binding (p value = 0.57, Fig-
ure S1C), indicating indirect regulation. To survey possible bio-
logical roles of Tcf3 direct targets, we performed Gene Ontology
analysis and found an overrepresentation of developmental
processes such as cell differentiation, anatomical structure
development, cell morphogenesis, and embryonic development
(Figure S1D). This is in line with the role of Tcf3 as a repressor of
pluripotency (Wray et al., 2011) and mediator of axial patterning
(Merrill et al., 2004).
For functional validation, we focused on genes associated
with cell differentiation and development and among them
selected transcription factors. This gave a short list of nine genes
(in bold in Figure S1E). We used gene expression analysis to test
responsiveness to the Gsk3 inhibitor Chiron99021 (CH). Four
genes showed very low expression with or without CH (data
not shown). The other five transcription factor genes exhibited
significantly increased expression in response to CH (Figure 2D,
orange columns). Esrrb, Klf2, Nanog, Nr0b1, and Tcfcp2l1 thus
emerge as candidate mediators of Gsk3/Tcf3-mediated ESC
self-renewal. Figure 2E shows gene tracks of Tcf3, Nanog, and
Oct3/4 binding at these five gene loci.
We also analyzed Tcf3 null cells and found an increased level
of expression of the five genes, similar to that in wild-type (WT)
cells treated with CH (Figure 2D, blue columns). Importantly,
when Tcf3 null cells were treated with CH, we did not observe
any further increase in expression (Figure S1F). These data indi-
cate that CH promotes the transcription of Esrrb, Klf2, Nanog,
Nr0b1, and Tcfcp2l1 through Tcf3 inhibition without requirement
for canonical activation through other Tcf/Lef family members (Yi
et al., 2011).
Esrrb Is Critical for Self-Renewal Downstream of the
Gsk3/Tcf3 Axis
Gsk3 deletion or inhibition is sufficient to maintain ESC self-
renewal in bulk culture for several passages, albeit with ongoing
differentiation (Doble et al., 2007; Wray et al., 2010; Ying et al.,
2008). This condition provides a stringent assay for downstream
gene requirement. To obtain a quantitative readout, we used
Rex1GFPd2 cells, in which a destabilized GFP protein is ex-
pressed from the Rex1 (Zfp42) locus (Wray et al., 2011). Rex1
is expressed specifically in ground state pluripotent cells and
is downregulated within 24 hr at the onset of differentiation
(Toyooka et al., 2008; Wray et al., 2010). Consequently the frac-
tion of undifferentiated ESCs in a population can be quantified
by flow cytometric analysis for GFP (Wray et al., 2011). We
knocked down the five transcription factor genes in Rex1GFPd2
cells by small interfering RNA (siRNA) transfection (Figure 2A).
Two different siRNAs were used for each gene (Figure S2A).
Cells were maintained in the presence of CH and evaluated by
flow cytometry (Figure 2B). ESCs treated with control siRNA
are mostly Rex1GFP-positive with a small shoulder of negative
cells. This profile is unaltered by siRNA against Nr0b1 while
Nanog knockdown induces only a small increase in the negative
fraction. The effect of Klf2 and Tcfcp2l1 siRNAs is rather more
pronounced, but in both cases the majority of cells remain
GFP-positive. In contrast, knockdown of Esrrb caused
a dramatic shift from Rex1GFP-positive to -negative (Figures
2B and 2C). This is not a selective elimination effect because
viable cell numbers determined by live cell gating were similar
in all conditions. To exclude nonspecific effects of siRNAs on
GFP expression, we confirmed a reduction in Rex1 transcript
(Figure 2D). Further qPCR analyses showed a marked
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downregulation in other pluripotencymarkers and a concomitant
increase in the early differentiation marker Fgf5 upon treatment
with siEsrrb.
To address whether decreased expression of Rex1 and plurip-
otency genes following Esrrb knockdown is associated
with compromised self-renewal, we tested ability to form
Figure 1. Identification of Tcf3 Direct Targets in Mouse ESCs
(A) Flow chart illustrating the approach used to identify candidate genes that mediate self-renewal downstream of Tcf3.
(B) Venn diagram showing overlap of Nanog, Oct3/4, and Tcf3 bound genes (see Experimental Procedures).
(C) Venn diagram showing overlap between genes upregulated (>1.4-fold change) in Tcf3 null cells, genes upregulated in Tcf3 knockdown, and genes bound by
Tcf3, Oct3/4, and Nanog. Fifty genes are identified as candidate Tcf3 direct targets.
(D) Gene expression analysis of WT ESCs treated with the Gsk3 inhibitor (CH) for the indicated times (orange columns), and of Tcf3 null ESCs (blue columns). All
cultures were in LIF+serum. The fold change expression relative to WT ESCs treated with vehicle (DMSO) is shown on a logarithmic scale. Mean and SD of two
independent experiments is shown.
(E) Gene tracks represent binding of Nanog, Oct3/4, and Tcf3 at the indicated gene loci. The x axis represents the linear sequence of genomic DNA and the y axis
represents the total number of mapped reads (see Experimental Procedures).
See also Figure S1.
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undifferentiated colonies 48 hr after siRNA transfection. Cells
were plated at single cell density in 2i+LIF and after 5 days
stained for alkaline phosphatase (AP). AP activity is a classical
marker of undifferentiated ESCs but does not reliably discrimi-
nate them from postimplantation epiblast stem cells (EpiSCs)
(Bao et al., 2009). However, EpiSCs differentiate or die in 2i
(Guo et al., 2009), therefore in this condition themarker is reliably
indicative of ESC status. Cells transfected with a control siRNA
(siControl) or siRNA targeting eGFP (siGFP) gave rise to
numerous AP-positive colonies, while knockdown of Nr0b1,
Nanog, Klf2, or Tcfcp2l1 caused up to 2-fold reduction (Fig-
ure 2E). Knockdown of Esrrb had a much stronger effect,
however, almost entirely eliminating AP-positive colonies (Fig-
ure 2E, green columns).
Previously, we reported that CH promotes self-renewal by
relieving Tcf3 repression (Wray et al., 2011). The expression of
each of the five candidate genes is elevated in Tcf3 null cells (Fig-
ure 1D). We therefore examined their importance for the ability of
ESCs lacking Tcf3 to self-renew efficiently without requirement
for CH. We knocked down the genes in Tcf3 null cells and tested
Figure 2. Esrrb Is Required to Mediate Self-Renewal Downstream of GSK3
(A) Experimental scheme for testing the functional requirement of the candidate genes identified in Figure 2. Rex1-GFPd2 cells were cultured in presence of the
Gsk3 inhibitor (Chiron-N2B27) for two passages and transfected with two independent siRNAs for each candidate gene. Cells were harvested 48 hr after
transfection and analyzed by flow cytometry (Rex1-GFP profile), quantitative PCR, and colony formation.
(B) Rex1-GFPd2 cells were transfected with the indicated siRNAs and analyzed after 48 hr by flow cytometry. One representative plot for knockdown of each gene
is shown. The dashed line indicates the threshold used to separate GFP-positive and GFP-negative cells.
(C) Quantification of the flow cytometry data for Rex1-GFPd2 cells transfected with the indicated siRNAs. Columns show the number of GFP positive cells
normalized to the negative control siRNA (siControl). Mean and SD of six independent experiments is shown.
(D) Gene expression analysis of Rex1-GFPd2 cells transfected with two independent siRNAs targeting Esrrb or two negative control siRNAs (siControl and
siGFP). GAPDH was used as endogenous control and data are normalized to the siControl sample. Mean and SD of four independent experiments is shown.
(E) Clonogenicity assay on Rex1-GFPd2 cells transfected with the indicated siRNAs. Forty-eight hr after transfection, cells were replated at clonal density in 2i +
LIF and stained for AP after 5 days. Columns show the number of AP+ve colonies normalized to the siControl. Mean and SD of four independent experiments is
shown.
(F) Clonogenicity assay of Tcf3 null cells transfected with the indicated siRNAs. Tcf3 null cells cultured in PD were transfected with the indicated siRNAs; after
48 hr they were replated at clonal density in PD and stained for alkaline phosphatase after 5 days. Columns show the number of AP+ve colonies normalized to the
negative control siRNA (siControl). Mean and SD of three independent experiments is shown. See also Figures S2B–S2D.
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ability to form colonies in the presence of the Mek inhibitor
PD0325901 (PD) alone. Null cells transfected with either
siControl or siGFP readily generated AP-positive colonies (Fig-
ure2F,bluecolumns). Klf2andTcfcp2l1siRNA treatment resulted
in slightly fewer colonies, whereas knockdown of Esrrb or Nanog
almost eliminated colony formation (Figure 2F, green and purple
columns). We also used titrated siRNA to partially reduce Esrrb
expression to levels close to those in WT ESCs (Figures S2B
and S2C). This resulted in restoration of colony formation to
similar numbers as for WT ESCs (Figure S2D). Taken together,
these results suggest that Esrrb is necessary to mediate self-
renewal downstream of Gsk3 inhibition and Tcf3 derepression.
Esrrb Expression Reproduces the Effect of Gsk3
Inhibition on Self-Renewal
We then examined whether expression of Esrrb or the other
factors may be sufficient to substitute for Gsk3 inhibition.
Rex1GFPd2 cells maintained in 2i were transfected with Piggy-
bac expression vectors (Guo et al., 2009). Following hygromycin
selection for two passages in 2i, the response to inhibitor with-
drawal was tested in colony forming assays and in bulk culture
(Figures 3A and 3B). PB-vector and PB-Tcfcp2l1 transfectants
yielded negligible colonies when plated at clonal density in
N2B27 alone. PB-Nr0b1, PB-Nanog, and PB-Klf2 produced
some colonies but many fewer than in the presence of CH.
PB-Esrrb, however, generated undifferentiated colonies in
comparable number and size to those obtained in the presence
of CH. The absence of any significant additive effect when Esrrb
is overexpressed in the presence of CH (Figure 3A) suggests that
Esrrb is capable of fully recapitulating the effect of Gsk3 inhibi-
tion on ESC clonogenicity.
In bulk culture in the presence of PD alone, PB-vector and PB-
Tcfcp2l1 cells collapsed within two passages. Other transfec-
tants could be maintained longer but progressively lost
Rex1GFP expression (Figure 3B) and completely differentiated
or died by five passages. By contrast, PB-Esrrb cells could easily
be expanded in PD for more than 12 passages. Their Rex1GFP
profile showed only a small shoulder of GFP low cells and the
cells retained undifferentiated morphology (Figures 3B and
3C). PB-Esrrb cells in these conditions expressed Oct4, Sox2,
and Nanog at a level similar to control cells in 2i (Figure 3D,
orange columns). They showed reduced Klf4 and Klf5 but
increased Klf2.
We then tested whether expression of Esrrb could confer
clonal self-renewal in the presence of serum, which is normally
dependent on LIF. Colonies were scored as undifferentiated,
mixed, or differentiated according to the AP staining pattern
because serum supports the survival and proliferation of differ-
entiated cells. PB-vector cells formed undifferentiated colonies
only in the presence of LIF, whereas PB-Esrrb cells were equally
capable of generating AP-positive colonies without LIF (Fig-
ure 3E), similarly to PB-Nanog cells that serve as a positive
control. Strikingly, the combination of Esrrb overexpression
and LIF caused a further increase in the number of undifferenti-
ated colonies, indicating that Esrrb is in a parallel pathway to
LIF/Stat3. We also used this assay to examine whether Esrrb
could rescue the differentiation phenotype induced by overex-
pression of Tcf3. Indeed the generation of undifferentiated colo-
nies is diminished by transfection with PB-Tcf3 alone and
regained by cotransfection with PB-Esrrb (Figure 3E). Consistent
with the colony assay, Tcf3 transfectants showed reduced ex-
presson of Nanog that was restored by Esrrb (Figure S3A).
Esrrb-expressing cells formed undifferentiated AP-positive
colonies when LIF or Wnt signaling were blocked by a Jak inhib-
itor or DKK respectively (Figures S3B and S3C). Furthermore,
neither the LIF target Socs3 nor the Wnt target Axin2 showed
elevated expression (Figures S3D and S3E), confirming that
Esrrb does not act by stimulating these pathways. We also co-
cultured GFP labeled Esrrb transfectants with unlabelled WT
cells. After three passages in serum without LIF, the entire pop-
ulation was GFP-positive (Figure S3F), demonstrating that Esrrb
acts cell autonomously.
In unscreened PB-Esrrb cells, the expression of Esrrb is typi-
cally up to 6- to 8-fold higher than endogenous levels. This
creates the possibility of neomorphic effects. We therefore
transfected Rex1GFPd2 ESCs with an alternative PB-Esrrb
vector allowing capture of low expressors using G418 (Fig-
ure 3F). We screened for level of Esrrb expression and identi-
fied a pool in which Esrrb messenger RNA (mRNA) and protein
are constitutively expressed at levels comparable to those
found in control vector transfectants in 2i (Figures 3G and
3H). These PB-Esrrb-neo cells recapitulate the phenotype of
Esrrb overexpressing cells: in the absence of CH or LIF, they
can be cultured for multiple passages, they express pluripo-
tency markers (Figures 3G and 3I), and they self-renew at
clonal density (Figure 3J). We conclude that constitutive
expression of Esrrb at endogenous levels is sufficient to sustain
ESC self-renewal.
Because constitutive expression of Esrrb blocks differentia-
tion, transgene excision (Chambers et al., 2003; Niwa et al.,
2009) was necessary to determine whether ESCs maintained
by Esrrb retain pluripotency. After transfection with an excisable
vector, cells were clonally selected and expanded in serum
without LIF for 1 month. They were then transiently transfected
with a Cre expression vector followed by subcloning of DsRed-
positive cells in the presence of LIF (Figure 3K). These subclones
no longer expressed the Esrrb transgene and reacquired depen-
dency on LIF (bottom panels of Figure 3L and Figure S3H). Re-
verted cells were injected into blastocysts and gave rise to
chimeric embryos in which DsRed-expressing cells contributed
widely (Figure 3M).
Collectively, these results indicate that constitutive expression
of Esrrb can replace Gsk3 inhibition and furthermore maintain
self-renewal and pluripotency independently of LIF/Stat3.
Esrrb Is Dispensable for Self-Renewal in the Presence
of LIF
Although Esrrb appears essential for ESC propagation down-
stream of Gsk3 inhibition, the forced expression studies indicate
that it does not lie downstream of LIF/Stat3. Therefore Esrrb
might be dispensable in the presence of LIF, just as Stat3 can
be deleted when Gsk3 is inhibited (Ying et al., 2008). We tested
this hypothesis by knocking down Esrrb in Rex1GFPd2 cells
cultured in the presence of LIF and PD (Figure 4A). Under these
conditions we found that Esrrb siRNA had amodest effect on the
naive pluripotency marker Rex1 (Figures 4B and 4C) and caused
only a partial reduction in the ability to form undifferentiated colo-
nies (Figure 4D). These findings are in stark contrast with the near
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Figure 3. Esrrb Recapitulates the Effect of GSK3 Inhibition on ESC Self-Renewal
(A) Rex1-GFPd2 cells were cotransfected with pBase helper plasmid and a piggyBac vector containing Esrrb, Klf2, Nanog, Nr0b1, Tcfcp2l1, or no cDNA (PB-
vector); transfected cells were selected for two passageswith Hygromycin in 2i. Six hundred cells were then plated at clonal density in the basalmediaN2B27with
(+) or without () Chiron and stained for AP after 5 days. Columns show the number of AP+ve colonies. Mean and SD of three independent experiments is shown.
(B) Flow cytometry analysis of Rex1-GFPd2 transfectants cultured in the indicated conditions. PB-vector cells could not be maintained for more than two
passages in presence of theMek inhibitor PDwithout CH, whereas PB-Klf2, PB-Nanog, and PB-Nr0b1 cells could not bemaintained formore than four passages.
Only PB-Esrrb cells showed robust self-renewal under these conditions, expanding continuously for more than 12 passages.
(C) Phase contrast pictures of PB-vector transfected cells in 2i media and PB-Esrrb cells in presence of the Mek inhibitor PD.
(D) Gene expression analysis of Rex1-GFPd2 cells transfected with either an empty vector or PB-Esrrb and cultured in the indicated conditions. Two independent
PB-Esrrb transfections were carried out, generating two independent cell lines named ‘‘Rex1-GFPd2 PB-Esrrb A’’ and ‘‘Rex1GFPd2 PB-Esrrb B.’’ GAPDH was
used as endogenous control and data are normalized to PB-vector cells cultured in 2i media.
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elimination of self-renewal by Esrrb siRNA in the absence of LIF
(Figure 2).
To substantiate these findings, we generated ESCs in which
the Esrrb gene can be conditionally inactivated. Through serial
gene targeting, we inserted loxP sites to flank the second exon
of both alleles of Esrrb (Figure S4A). The second exon encodes
the start codon and part of the DNA-binding domain. Esrrb/
ESCs generated by Cre-mediated recombination are therefore
expected to be functionally null. Tamoxifen-regulatable Cre
was used to effect deletion. Homozygous deletion was
confirmed in a clonally expanded population by immunostaining
and qPCR (Figures 4E and 4F). These Esrrb null ESCs remained
morphologically undifferentiated in serum-containing medium
with LIF over multiple passages. Expression of some pluripo-
tency-associated genes, Klf4 and Tbx3, was reduced (Figure 4F)
and the null cells exhibited a rather more flattened morphology
(Figure 4H), but they showed similar proliferation to WT ESCs.
Interestingly, Nanog/ ESCs also show reduced expression of
Klf4 (Figure 4G). From examination of the ChIP-seq compen-
dium, Klf4 is a likely direct target of both Esrrb and Nanog, which
may explain its lower level in null cells.
When Esrrb null ESCs were cultured in serum-free conditions,
they expanded in 2i+LIF and LIF+PD. They were less compact
than parental cells but remained undifferentiated (Figure 4H)
with no overt compromise of proliferation or viability. However,
on LIF withdrawal, the null cells collapsed within one passage.
Thus, in the absence of Esrrb, ESCs lose the ability to respond
effectively to Gsk3 inhibition and their propagation appears
strictly dependent on LIF. Clonal analysis of Esrrb/ cells
confirmed these findings, showing a dramatic reduction in the
number of AP-positive colonies in the absence of LIF (Figure 4I,
compare 2i+LIF to 2i and LIF+PD to CH).
We carried out gene expression analysis after 48 hr of culture
either in LIF+PD or in CH (Figures 4K and 4L). In LIF+PD,
Esrrbfl/fl and Esrrb/ cells showed a comparable profile, apart
from reduced Klf4 and Tbx3 in the null cells (Figure 4K). In
contrast, after 48 hr in CH Esrrb/ cells showed lower expres-
sion of all pluripotency markers (Figure 4L). These deletion
findings are fully consistent with results obtained after Esrrb
knockdown (Figures 2 and 4A–4D), confirming that Esrrb is
essential for self-renewal downstream of CH, but can be
compensated for by LIF stimulation. In contrast, Nanog null
cells could be propagated under all conditions described
above, consistent with previous observations (Silva et al.,
2009) that Nanog is not required for responsiveness to Gsk3
inhibition (Figure 4J).
To explore why loss of Esrrb has more severe consequences
than deletion of Nanog, we utilized the ChIP-seq compendium
(Figure S1) to compare profiles of Nanog, Oct4, Sox2, Tcf3, and
Esrrb. As shown in Figure 4M using the Tbx3 locus as an
example, there are regions bound by Nanog, Oct4, Sox2,
Tcf3 (O/S/T) together with Esrrb (see blue box), as well as
regions bound only by Esrrb (see green box). Global analysis
revealed that a majority of the genomic regions bound by
Nanog are co-occupied by at least one of Oct4, Sox2, and
Tcf3 (O/S/T), as well as Esrrb. However, only a minority of
Esrrb-bound regions are occupied by any of the other four plu-
ripotency factors (Figure 4N; Figure S4C). To investigate
whether Esrrb-specific occupancy translates into Esrrb-specific
candidate target genes, we mapped binding peaks to genes
(see Table S1 and Experimental Procedures section) and inter-
sected the resulting gene lists. Whereas over 90% (2,921 out of
3,230) of the predicted Nanog target genes were also targets of
O/S/T and/or Esrrb, only 55% (1,992 out of 3,647) of Esrrb
candidate targets were shared with any of the other factors
(Figure 4O; Figure S4D). The extensive overlap of Nanog with
Oct4, Sox2, Tcf3, and/or Esrrb candidate targets may
explain why Nanog deletion can be tolerated in established
ESCs. Conversely, the wider occupancy of Esrrb is consistent
with the observation that Esrrb function is less readily
dispensable.
We then examined whether ESCs lacking Esrrb and main-
tained using LIF are pluripotent. Cells grafted under the kidney
capsule gave rise within 6 weeks to large multidifferentiated
tumors that contained neural, mesodermal, and endodermal
tissues along with undifferentiated embryonal carcinoma
(E) Clonogenicity assay of Rex1-GFPd2 cells transfected with the indicated plasmids and selected for two passages. Six hundred cells were plated at clonal
density in Serum media alone or with LIF and stained for AP after 5 days. Columns show the number of wholly AP+ve, mixed or wholly differentiated (AP-ve)
colonies. Mean and SD of three independent experiments is shown. See also Figure S3A.
(F) Rex1-GFPd2 cells in 2i were cotransfected with pBase helper plasmid and a piggyBac vector containing Esrrb-IRES-Neo (PB Esrrb IN); after 48 hr of culture in
2i, selection was applied and CH was withdrawn. Selection in low G418 (200 mg/ml) allowed isolation of transfectants expressing the Esrrb transgene at a level
similar to endogenous expression in CH-treated cells. Cells were cultured for >3 passages and analyzed as indicated.
(G) Gene expression analysis of Rex1GFP cells transfected with an empty vector (PB-vector) cultured in 2i, in PD for two passages, or Rex1GFP Esrrb IN cells
cultured in PD for three passages. Note that in Esrrb IN cells cultured in PD (orange columns), the expression of Esrrb ismaintained at levels comparable to control
cells cultured in 2i (blue columns). ActinB served as an internal control.
(H) Western blot of Rex1GFP cells transfected with an empty vector (PB-vector) cultured in 2i, and Rex1GFP Esrrb IN cells cultured in PD for three passages. For
each sample, three different amounts of total proteins (equivalent to 50,000, 25,000, and 12,500 cells) were loaded. Note that Esrrb protein levels are comparable
in the two samples. GAPDH served as a loading control.
(I) Rex1GFP cells transfected with an empty vector (PB-vector) cultured in 2i for three passages, and Rex1GFP Esrrb IN cells cultured in PD for three passages
have been analyzed by flow cytometry. Seventy-nine percent of Esrrb IN cells were GFP-positive.
(J) Rex1GFP cells transfected with an empty vector (PB-vector) cultured in 2i for three passages, and Rex1GFP Esrrb IN cells cultured in PD for three passages
have been plated at clonal density in N2B27+PD and stained for alkaline phosphatase after 5 days. As expected, PB-vector cells could not form AP+ colonies (top
panel), whereas Rex1GFP Esrrb IN cells did (bottom panel).
(K) Cre excisable construct used for Esrrb overexpression.
(L) Representative pictures of cells transfected with the Esrrb excisable construct before (Esrrb+) and after excision (Esrrb-). Note that only Esrrb+ cells can be
cultured in serum containing media without LIF. Successful excision was confirmed by PCR using transgene-specific primers (Figure S3H).
(M) Esrrb excised ESCs contribute to chimeric embryos. The DsRed signal is specifically detected in the injected embryos at midgestation and not in a sibling
embryo with no chimeric contribution (control).
Cell Stem Cell
Esrrb Sustains Pluripotency
Cell Stem Cell 11, 491–504, October 5, 2012 ª2012 Elsevier Inc. 497
Figure 4. Esrrb Is Not Required for Self-Renewal in the Presence of LIF
(A) Rex1-GFPd2 cells were cultured in N2B27 plus LIF and PD03 for two passages and transfected with two independent siRNAs targeting Esrrb or two negative
control siRNAs (siControl and siGFP). Cells were harvested 48 hr after transfection and analyzed by flow cytometry (Rex1-GFP profile), quantitative PCR, and
clonal analysis.
(B) Rex1-GFPd2 cells were transfected with the indicated siRNAs and analyzed after 48 hr by flow cytometry. Columns show the number of GFP-positive cells
normalized to the negative control siRNA (siControl). Mean and SD of three independent experiments is shown.
(C) Gene expression analysis of Rex1-GFPd2 cells transfected with two independent siRNAs targeting Esrrb or two control siRNAs (siControl and siGFP). GAPDH
was used as endogenous control and data are normalized to the siControl. Mean and SD of three independent experiments is shown.
(D) Quantification of clonogenicity assay of Rex1-GFPd2 cells transfected with the indicated siRNAs. Forty-eight hr after transfection, cells were replated at clonal
density in 2i media and stained for AP after 5 days. Columns show the number of AP+ve colonies normalized to the siControl. Mean and SD of three independent
experiments is shown.
(E) Immunostaining of Esrrb/ and Esrrbfl/fl cells confirming absence of Esrrb protein in the Esrrb/ cells.
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(Figure 5A). The tumors showed no overt differences in size or
differentiation from teratocarcinomas generated by Esrrbfl/fl
cells. Most significantly, the embryonic identity and develop-
mental potential of Esrrb null cells was confirmed by integration
into the inner cell mass after aggregation with morulae (Figures
5B and 5C) and widespread contribution to the midgestation
embryo after blastocyst injection (Figure 5D; Figure S5).
Direct Regulation of Esrrb Expression by the Gsk3/
b-Catenin/Tcf3 Axis
In keeping with several other core pluripotency factors, Esrrb is
expressed in a mosaic fashion in ESCs cultured in serum.
When CH is added to the cultures, however, Esrrb immuno-
staining becomes more uniform and increased in intensity
(Figures 6A and 6B). To confirm binding of Tcf3 to the Esrrb
gene, we carried out single point ChIP assays at five regions
detected in previous ChIP studies (Cole et al., 2008; Marson
et al., 2008). Marked enrichment was observed in WT ESCs
compared with Tcf3 null cells (Figure 6C). As noted above,
Tcf3 null ESCs show elevated expression of Esrrb that is not
further induced by CH alone. We repeated this analysis in
the presence of LIF and PD and obtained similar results (Fig-
ure 6D). b-catenin null ESCs also fail to upregulate Esrrb in
response to CH, consistent with their inability to self-renew
without LIF (Wray et al., 2011). These data confirm that both
Tcf3 and b-catenin are necessary for Esrrb induction by
Gsk3 inhibition. We found that Wnt3a can induce Esrrb,
although to lower levels than CH (Figure S6), likely reflecting
the operation of negative feedback in the canonical Wnt
pathway that can be short-circuited by Gsk3 inhibition. Finally,
we investigated the possibility that induction of Esrrb may
involve Nanog. Nanog is modestly upregulated by both CH
and Tcf3 ablation (Figure 1D) and it has been shown to bind
to the Esrrb promoter region (Chen et al., 2008). We found
that Esrrb is fully induced by CH in Nanog null ESCs (Figure 6E).
Steady state expression is lower in the absence of Nanog,
however (see also Figure 4G). We conclude that Nanog plays
a role in maintenance of Esrrb expression level, but that induc-
tion by Gsk3 inhibition is mediated directly by abrogation of
Tcf3 repression (Figure 6F).
DISCUSSION
Several mechanisms have been proposed through which inhibi-
tion of Gsk3 may stabilize the naive state of mouse ESCs (Cole
et al., 2008; Kelly et al., 2011; Sokol, 2011; Wray et al., 2011;
Yi et al., 2011). The present analyses clarify this debate by iden-
tifying Esrrb as a direct functional target of Tcf3 that is dere-
pressed downstream of Gsk3 inhibition. Perturbation studies
demonstrate that Esrrb activity is both necessary and sufficient
for the response to Gsk3 inhibition. Notably, Esrrb exhibits mark-
edly more potent capacity than other Tcf3 targets to suppress
differentiation, sustain propagation, and maintain key pluripo-
tency genes. While recognizing that Tcf3 also regulates other
key genes in the pluripotency circuitry, these findings pinpoint
Esrrb as the main effector through which the Gsk3/b-catenin/
Tcf3 axis modulates ESC self-renewal.
We generated a compendium of publicly available ChIP-seq
data for 38 transcriptional regulators in mouse ESCs (Figures
S1A and S1B). This integrated resource with a unified data struc-
ture enables streamlined cross-referencing of individual data
sets from different laboratories. Distinct clusters of binding
profiles can be discerned that appear to partition the ESC tran-
scriptional program into several major subcompartments. The
compendium thus provides a powerful analytical tool with the
potential to fuel new hypotheses on the transcriptional control
of ESC function. Tcf3 binds at a large number of sites, including
many genes implicated in ESC biology (Cole et al., 2008; Marson
et al., 2008; Tam et al., 2008). We used the compendium
resource to examine in greater detail genes bound by both
Tcf3 and core pluripotency factors and generate a refined list
of candidate targets, which included Esrrb.
Esrrb is an orphan nuclear receptor related to the estrogen
receptor (Luo et al., 1997). A potential role in ESCs was previ-
ously suggested from results of an RNAi screen by Ivanova
and colleagues who found that knockdown of Esrrb reduced
ESC self-renewal efficiency and promoted differentiation (Iva-
nova et al., 2006). Subsequently, Esrrb was reported to replace
Klf4 in fibroblast reprogramming, albeit with reduced efficiency
(Feng et al., 2009). Through protein interaction studies, Esrrb
was found to bind to Oct4 and cooperate in transcriptional
(F) Gene expression analysis of Esrrb/ and Esrrbfl/fl cells cultured in LIF+Serum. Note the absence of Esrrb transcript. GAPDHwas used as endogenous control
and data are normalized to Esrrbfl/fl cells.
(G) Gene expression analysis of Nanog/ and Nanog+/ cells cultured in LIF+Serum. Note the absence of Nanog transcript. GAPDH was used as endogenous
control and data are normalized to Nanog+/ cells.
(H) Phase contrast images of Esrrbfl/fl and Esrrb/ cells under the indicated culture conditions.
(I and J) Colony forming assay on Esrrbfl/fl and Esrrb/ (I), and Nanog/ and Nanog+/ (J) cells. Cells were cultured in 2i+LIF, plated at clonal density (300 cells
per well) under the indicated conditions, and stained for alkaline phosphatase after 5 days. Columns show the number of AP+ve colonies. Mean and SD of three
independent experiments is shown.
(K and L) Esrrbfl/fl and Esrrb/ ESCs were cultured for 48 hr in LIF+PD (K) or CH (L) and analyzed by qPCR for the indicated pluripotency markers. GAPDH was
used as endogenous control and data are normalized to Esrrbfl/fl. Mean and SD of two independent experiments is shown.
(M) Gene tracks representing binding of Nanog, Oct3/4, Sox2, Tcf3, and Esrrb at the Tbx3 gene locus. The x axis represents the linear sequence of genomic DNA,
and the y axis represents the total number of mapped reads. A blue box highlights a region where the five factors colocalize while the green box highlights a region
bound only by Esrrb.
(N) Venn diagram showing the intersection between the genomic regions bound by at least one factor among Oct3/4, Sox2, and Tcf3 (O/S/T in blue), by Nanog (in
red) and by Esrrb (in green). For this diagram, only the top 5,000 ChIP-Seq peaks of each factor have been used, in order to account for differences in ChIP
efficiency among different factors. See also Figure S4C.
(O) Venn diagram showing the intersection between the predicted target genes bound by at least one factor amongOct3/4, Sox2, and Tcf3 (O/S/T in blue), and the
predicted target genes of Nanog (in red) or Esrrb (in green). Only the top 5,000 peaks for each factor have been used to predict target genes in order to account for
differences in ChIP efficiency. See also Figure S4D and Table S5.
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regulation of Nanog (van den Berg et al., 2008). Esrrb is also
proposed to interact with Nanog and thereby play a reciprocal
role in regulation of Oct4 expression (Zhang et al., 2008). These
authors also reported that overexpression of Esrrb can support
formation of AP colonies in serum in the absence of LIF (Zhang
et al., 2008). However, the identity of the colonies was not char-
acterized further and neither self-renewal nor retention of plurip-
otency were investigated. Nor is there any evidence that Esrrb is
induced by LIF. In the embryo, deletion of Esrrb causes midges-
tation lethality due to placental defects (Luo et al., 1997), but
mutant embryos develop through implantation and gastrulation.
Furthermore, tetraploid complementation rescued embryo
development at least to midgestation (Luo et al., 1997), confirm-
ing that there is no defect in the ICM or epiblast. Hence the
functional significance of Esrrb in ESCs and its position in the
regulatory hierarchy have been uncertain.
Here, through loss-of-function studies by siRNA knockdown
and definitive gene deletion via homologous recombination, we
established that Esrrb is specifically required for the self-renewal
effect of Gsk3 inhibition. Furthermore, Esrrb gain-of-function can
replace Gsk3 inhibition and support long-term ESC propagation
in the presence of Mek inhibition alone. Constitutive expression
of Esrrb can also confer clonogenic LIF-independent self-
renewal in serum. Importantly, ESCs propagated under the
direction of Esrrb remain pluripotent and capable of colonizing
chimeras when the transgene is removed.
Mouse ESC self-renewal is highly responsive to LIF, acting
through Jak kinase and the downstream transcription factor
Stat3 (Matsuda et al., 1999; Niwa et al., 1998). Neither LIF nor
Gsk3 inhibition alone can fully suppress ESC differentiation,
but the combination of both together is very effective (Wray
et al., 2010). Furthermore, Stat3 null ESCs can be derived and
maintained using 2i and are functionally nonresponsive to LIF
(Ying et al., 2008), whereas b-catenin null ESCs self-renew in
the presence of LIF but do not respond to Gsk3 inhibition (Lya-
shenko et al., 2011; Wray et al., 2011). These observations indi-
cate that Gsk3 inhibition/Tcf3 derepression supports self-
renewal in parallel with LIF/Stat3 and inputs independently into
the core pluripotency network (Figure 6F). Indeed, although
Esrrb expression can act dominantly to confer LIF indepen-
dence, addition of LIF further augments clonogenic capacity.
Consistent with parallel pathways, the requirement for Esrrb is
not absolute. ESCs lacking Esrrb remain undifferentiated if
cultured in the presence of LIF with either PD or serum. Thus
the need for Esrrb, just as for Gsk3 inhibition or b-catenin (Lya-
shenko et al., 2011; Wray et al., 2011), is conditional on whether
ESCs receive other pro- and antidifferentiation stimuli, in partic-
ular LIF. Parallel compensatory capacity could explain why the
pluripotent lineage in the early embryo can developwithout Esrrb
(Luo et al., 1997).
When Esrrb knockdown or knockout ESCs are cultured
without LIF, they downregulate pluripotency genes and exit
self-renewal. We therefore conclude that Esrrb is a component
of the core transcription factor network that underpins pluripo-
tency. Esrrb appears to be highly interconnected with other
pluripotency factors by both protein interactions and transcrip-
tional cross-regulation (van den Berg et al., 2008; van den Berg
et al., 2010; Zhang et al., 2008). Interestingly, examination of
Figure 5. Esrrb Null Cells Are Pluripotent
(A) Esrrb/ ESCs cultured in LIF+serum were injected into the kidney capsule and produced teratocarcinomas containing tissues representative of the three
germ layers (epidermis for ectoderm, kidney and striated muscle for mesoderm and gut-like epithelia for endoderm) along with undifferentiated embryonal
carcinoma (EC) cells.
(B) Esrrb/ ESCs contribute to chimeric embryos: summary of the experiments performed with GFP-labeled Esrrb/ ESCs. See also Figures S5A and S5B.
(C) GFP-labeled Esrrb/ ESCs cultured in either 2i+LIF or LIF/PD, were combined with 8-cell stage embryos, cultured in vitro for 48 hr, and scored for the
presence of GFP-positive cells in the ICM. A representative image is shown.
(D) Blastocyst injection was performed followed by embryo transfer and embryos were scored at midgestation (E12.5) for the presence of GFP-positive cells.
Esrrb fl/fl served as a positive control. See also Figures S5A and S5B.
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Figure 6. Mechanism of Esrrb Regulation by Tcf3
(A) Fluorescence micrographs showing immunostaining for Esrrb of WT ESCs cultured under the indicated conditions.
(B) Histogram showing the distribution of Esrrb immunostaining intensity under the indicated conditions. More than 3,000 single ESCs for each condition were
analyzed and divided into three categories based on staining intensity (see Experimental Procedures section).
(C) Top shows that gene tracks represent binding of Tcf3 at the Esrrb gene locus. The five red boxes indicate the regions analyzed by ChIP for Tcf3. Bottom shows
that ChIP for Tcf3 followed by qPCR for the indicated regions was performed in either WT or Tcf3 null cells. Enrichment over a mock ChIP is shown. Mean and SD
of three independent experiments is shown.
(D) Esrrb expression analysis of the indicated ESC lines, cultured in LIF/PD and treated with the Gsk3 inhibitor (CH) for 24 hr (orange columns). The fold change
expression relative to LIF/PD is shown; ActinB served as an internal control. Mean and SD of two independent experiments is shown.
(E) Gene expression analysis of Nanog +/ and / cells, cultured in LIF/PD and treated with the Gsk3 inhibitor (CH) for 8 hr or 24 hr (orange columns). GAPDH
served as an internal control. Mean and SD of two independent experiments is shown.
(F) Schematic representation of core pluripotency transcription factor circuit with parallel input from LIF/Stat3 and GSK3 inhibition/Tcf3 derepression.
See also Figure S6.
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the ChIP-seq compendium reveals that although Esrrb binds at
many of the same genes as other core pluripotency factors
(Nanog, Oct4, Sox2, Tcf3), it often occupies different sites. In
addition, Esrrb is located at a large group of genes not bound
by the other factors. These observations are consistent with
the functional evidence that Esrrb makes a distinctive contribu-
tion to ESC self-renewal. Indeed, we find that Esrrb binding is de-
tected at 70% of genes (8,149 out of 12,051) that show signif-
icant expression by RNA-seq (>0.5 RPKM) in ground state ESCs
(Marks et al., 2012). This suggests that it may play a generalized
role in ESC transcription, particularly when considered with
evidence that Esrrb interacts physically with components of
the basal transcriptional machinery (van den Berg et al., 2010).
In summary, these findings place Esrrb on a par with Nanog,
Klf4, Klf2, and Tbx3 in the pantheon of intrinsic pluripotency
factors that together with Oct4 and Sox2 establish and sustain
naive ESCs (Figure 6F). Specifically, Esrrb is a direct target of
Tcf3 repression and the principal factor mediating the self-
renewal response to Gsk3 inhibition and stabilization of b-cate-
nin. Esrrb acts independently of LIF/Stat3, conferring flexibility
and robustness to naive ESC self-renewal. Future work will
explore the mutual compensation and plasticity in the pluripo-
tency gene regulatory network that allows LIF stimulation to
accommodate deletion of Esrrb. It will also be of interest to
examine epiblast development in blastocysts doubly deficient
for Esrrb and Stat3. Finally, we note that Esrrb is not significantly
expressed in mouse postimplantation epiblast stem cells
(EpiSCs), nor in currently available human pluripotent stem cells,
neither of which show a self-renewal response toGsk3 inhibition.
EXPERIMENTAL PROCEDURES
Generation of ChIP-seq Compendium
Processed data files (density maps, wig format; peak coordinates, bed format)
were acquired from the NCBI Gene Expression Omnibus (GEO) and Short
Sequence Read Archive (SRA). They were displayed in the UCSC Genome
Browser allowing a visual inspection of the ChIP-seq data and peak calling
quality. Where the published peak coordinates appeared to over- or underpre-
dict, or were unavailable, creation of density maps and peak calling was per-
formed de novo using the mapped reads as described (Hannah et al., 2011).
The specific peak parameters used are indicated in Table S1.
A binary peak matrix was generated as described (Hannah et al., 2011),
analyzed by unsupervised hierarchical clustering using Pearson correlation
coefficients, and displayed using the heatmap function in R (Figure S1A).
Lists of candidate target genes for all factors have been generated by peak-
to-gene mapping using the same uniform parameters for all studies, which
may be different from the parameters used in the individual original studies.
The requirements used are as follows: if a TF peak is within 100 bp of the
TSS, it is associated with that gene alone; all other peaks can be associated
with up to two genes, by examining 50 kb of flanking sequence on either
side of the peak.
The lists of candidate targets have been analyzed by unsupervised hierar-
chical clustering using Pearson correlation coefficients, and displayed using
the heatmap function in R (Figure S1B). All raw and processed data files
used for this study are available for download from http://bioinformatics.
cscr.cam.ac.uk/ES_Cell_ChIP-seq_compendium.html. The gene tracks have
been generated by loading the density maps of the indicated factors into the
UCSC genome browser as custom tracks.
The ChIP-seq data used for peaks intersection, target gene intersection,
and gene tracks (in Figures 1 and 4) are as follows: Esrrb, GSE11431
(GSM288355); Nanog, GSE11724 (GSM307140 and GSM307141); Oct4,
GSE11724 (GSM307137); Sox2, GSE11724 (GSM307138 and GSM307139);
Tcf3, GSE11724 (GSM307142 and GSM307143).
Embryonic Stem Cell Culture
ESCs were cultured without feeders on plastic coated with 0.1% gelatine
(Sigma, cat. G1890) and replated every 3 days at a split ratio of 1 in 10 following
dissociation with Accutase (PAA, cat. L11-007). Cells were cultured either in
the GMEM (Sigma, cat. G5154) supplemented with 10% FCS (Sigma, cat.
F7524), 100 mM 2-mercaptoethanol (Sigma, cat. M7522), 13MEM nonessen-
tial amino acids (Invitrogen, cat. 1140-036), 2 mM L-glutamine, 1 mM sodium
pyruvate (both from Invitrogen), and 100 units/ml LIF, or in the serum-free
media N2B27 (NDiff N2B27 base medium, Stem Cell Sciences Ltd, cat.
SCS-SF- NB-02) supplemented, as indicated, with small-molecule inhibitors
PD (1 mM, PD0325901) and CH (3 mM, CHIR99021) and LIF prepared in-house.
Colony forming assays were carried out by plating 600 ESCs per well on plates
coated with laminin (Sigma, cat. L2020). Plates were fixed and stained for AP
(Sigma, cat. 86R-1KT) according to the manufacturer’s protocol. Plates were
scanned using a CellCelector (Aviso) and scored manually.
Gene Expression Analysis by Quantitative PCR with Reverse
Transcription
Total RNA was isolated using the RNeasy Kit (QIAGEN) and complementary
DNA (cDNA) was made from 500 ng using SuperScriptIII (Invitrogen) and
oligo-dT primers. For real-time PCR, we used TaqMan Fast Universal Master
Mix and TaqMan probes (Applied Biosystems) or the Universal Probe Library
(UPL, Roche) system. In Figures 4F, 4J, and 4K, we used SYBR green system.
Primers and UPL probe numbers are detailed in Table S2. Technical replicates
were carried out for all quantitative PCR reactions. An endogenous control
(Gapdh, glyceraldehyde-3-phosphate dehydrogenase, Applied Biosystems
4352339E) was used to normalize expression.
RNAi Experiments
siRNAs were transfected at a final concentration of 40 nM using Dharmafect 1
(Dharmacon, cat. T-2001-01), following the protocol for reverse transfection.
For a 12-well plate (4cm2), we used 2 ml of transfection reagent, 2 ml of
20 microM siRNA solution, and 30,000 ESCs in 1 ml of N2B27 medium. The
mediumwaschangedafter overnight incubation; 48hrafter transfection, thecells
were analyzed as indicated. See Table S3 for sequences of the siRNAs used.
Flow Cytometry
After treatment with Accutase, live ESCs were resuspended in PBS with 3%
FCS and ToPro-3 (Invitrogen) was added at a concentration of 0.05 nM to
detect dead cells. Flow cytometry analyses were performed using a Dako Cy-
tomation CyAn ADP high-performance cytometer with Summit software.
Essrb Gene Targeting
LoxP sites were inserted to flank exon2 of Esrrb using a promoter-trap vector
containing an FRT flanked SA-IRES-bgeo selection cassette (Figure S4).
Subsequent transfection with the FLPe expression vector removed this
cassette to generate Esrrbfl/+ ESCs. Targeting was confirmed by genomic
PCR. This strategy was repeated for the second allele to create homozygous
Esrrbfl/fl ESCs. To enable efficient conditional deletion, we stably trans-
fected cells with an expression vector for the tamoxifen-inducible form of
Cre (MerCreMer). Null cells were obtained by treatment with 200ng/ml of
Tamoxifen for 3 days and expanded from single cells in medium containing
serum and LIF.
Mouse studies were carried out in a designated facility under licenses
granted by the UK Home Office.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, five tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2012.06.008.
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